Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fabris

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The American Journal of Gastroenterology|July 16, 1999
Triple therapy prevents HIV but not HCV transmission after needlestick injuryP Fabris, V Manfrin, M Rassu, et al.
Journal of Medical Virology|April 4, 2000
GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in ItalyL Romanŏ, P Fabris, E Tanzi, et al.
Clinical Chemistry|May 5, 2000
Improved molecular diagnosis of hereditary hemochromatosis using a DNA enzyme immunoassayM R Biasin, T Bertin, G Sardeo, et al.
Haematologica|May 1, 1985
[Incidence of thalassemia in Alto Adige: statistical study of the population of the Italian ethnic group]L Salerno, P Coser, O Prinoth, et al.
Current Pharmaceutical Design|July 29, 2004
Therapy of chronic hepatitis C virus infection in HIV co-infected peopleP Fabris, E Barnes, G Tositti, et al.
Infection|May 1, 1993
Cryptococcal pleural effusion as first indicator of AIDS: a case reportF de Lalla, A Vaglia, M Franzetti, et al.
Alimentary Pharmacology & Therapeutics|October 30, 1999
Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patientsP Fabris, G Tositti, F Negro, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2002
Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infectionP Fabris, A Pilotto, L Bozzola, et al.
Diabetes Care|August 11, 2000
Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infectionC Betterle, P Fabris, R Zanchetta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short periodF de Lalla, G Pellizzer, A Vaglia, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The American Journal of Gastroenterology|July 16, 1999
Triple therapy prevents HIV but not HCV transmission after needlestick injuryP Fabris, V Manfrin, M Rassu, et al.
Journal of Medical Virology|April 4, 2000
GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in ItalyL Romanŏ, P Fabris, E Tanzi, et al.
Clinical Chemistry|May 5, 2000
Improved molecular diagnosis of hereditary hemochromatosis using a DNA enzyme immunoassayM R Biasin, T Bertin, G Sardeo, et al.
Haematologica|May 1, 1985
[Incidence of thalassemia in Alto Adige: statistical study of the population of the Italian ethnic group]L Salerno, P Coser, O Prinoth, et al.
Current Pharmaceutical Design|July 29, 2004
Therapy of chronic hepatitis C virus infection in HIV co-infected peopleP Fabris, E Barnes, G Tositti, et al.
Infection|May 1, 1993
Cryptococcal pleural effusion as first indicator of AIDS: a case reportF de Lalla, A Vaglia, M Franzetti, et al.
Alimentary Pharmacology & Therapeutics|October 30, 1999
Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patientsP Fabris, G Tositti, F Negro, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2002
Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infectionP Fabris, A Pilotto, L Bozzola, et al.
Diabetes Care|August 11, 2000
Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infectionC Betterle, P Fabris, R Zanchetta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short periodF de Lalla, G Pellizzer, A Vaglia, et al.
Pageof 8